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Putting insulin resistance into context by 
dietary reversal of type 2 diabetes
r taylor1
It has long been assumed that type 2 diabetes is caused by the combined 
effects of insulin resistance and loss of pancreatic islet beta cells. Much 
therapeutic effort has been directed towards decreasing insulin resistance 
even though results have been generally disappointing. Now that type 2 
diabetes can be understood as a simple reversible condition, its component 
parts can be examined during the period of return to normal glucose 
tolerance. 
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Abstract
What is insulin resistance?
any individual will respond to a fi xed dose of insulin in a 
manner depending upon the degree of sensitivity to insulin. 
at the one end of the spectrum, slim athletic people are likely 
to be very sensitive to insulin, whereas obese inactive people 
are likely to be relatively insensitive, or insulin resistant. 
different tissue exhibit different sensitivity to insulin, but the 
phrase ‘insulin resistance’ has become synonymous with 
results of euglycemic hyperinsulinemic clamp studies. these 
tests predominantly measure muscle insulin sensitivity.1
insulin resistance in muscle is the earliest indicator of risk of 
future development of type 2 diabetes.2 it has been assumed 
that reversing the insulin resistance would considerably 
improve the level of blood glucose control in established type 
2 diabetes, and much therapeutic effort has been directed 
at the targeted insulin resistance. however, even vigorous 
exercise training produces only a modest effect on blood 
glucose control.3 similarly, drugs developed specifi cally to 
improve insulin resistance – thiazolidinediones – produce 
only modest benefi t.4 
it is the insulin sensitivity of a different organ which is most 
closely associated with control of fasting plasma glucose. the 
liver is responsible for continuous production of glucose. this 
is essential to survival as the brain requires a continuous 
supply of glucose for its energy needs in everyday life. 
especially during the overnight period, life continues only 
because the liver produces around 10 g of glucose per hour.5 
this is regulated by insulin, and hence any degree of insulin 
resistance in this process would lead to increased production 
of glucose. indeed, fasting plasma insulin is typically raised 
in type 2 diabetes, but nonetheless the liver produces around 
15 g of glucose per hour.6 
Predictions of the twin cycle hypothesis
in 2008 it was possible to bring together information on 
control of liver glucose production and beta cell function to 
postulate the events leading to the onset of type 2 diabetes 
(figure 1).7 
type 2 diabetes only occurs after a decade or more of positive 
energy balance. any fat in excess of daily requirement for 
oxidation can be stored in subcutaneous tissue but any 
excess carbohydrate can be handled only by one pathway: 
conversion to triglyceride. this happens solely in the liver 
and is promoted by the presence of high insulin levels. the 
pathway is not subject to insulin resistance, so individuals 
who are relatively insulin resistant have modestly raised 
plasma insulin levels and will be able to convert carbohydrate 
into liver fat more readily. the fi rst step in the twin cycle 
hypothesis is that the levels of fat inside the liver gradually 
rise and this brings about increasing liver insulin resistance. 
in order to control the output of glucose by the liver, plasma 
insulin levels must rise. it creates a vicious cycle leading to 
steadily increasing liver fat levels. 
the higher the liver fat level, the higher the rate of export of 
triglyceride to the rest of the body. this is done in the form of 
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Figure 1 the twin cycle hypothesis
during chronic positive calorie balance, any excess carbohydrate 
must undergo de novo lipogenesis. there is no other available 
pathway, and it can only occur in the liver. this particularly promotes 
fat accumulation in the liver. as insulin stimulates de novo 
lipogenesis, individuals with a degree of insulin resistance 
(determined by family or lifestyle factors) will increase liver fat more 
readily than others due to the higher plasma insulin levels. the 
increased liver fat will cause relative resistance to suppression of 
hepatic glucose production by insulin. over many years, this will bring 
about a small increase in fasting plasma glucose level, and hence 
increased basal insulin secretion rates. the consequent 
hyperinsulinemia will further enhance the conversion of excess 
calories into liver fat. a vicious cycle of hyperinsulinemia and blunted 
suppression of hepatic glucose production becomes established. 
fatty liver leads to increased export of vldl triacylglycerol21 which 
will increase fat delivery to the islets of the pancreas along with all 
other tissues. this process is further stimulated by elevated plasma 
glucose levels.21 excess fatty acid availability in the pancreatic islet 
will bring about beta-cell de-differentiation22–24 and impair the acute 
insulin secretion in response to ingested food. at a certain level of 
fatty acid exposure, postprandial hyperglycaemia will develop. the 
hyperglycaemia will further increase insulin secretion rates and 
hepatic lipogenesis, spinning the liver cycle faster and promoting the 
pancreas cycle. eventually the fatty acid and glucose inhibitory 
effects on the islets reach a trigger level leading to a relatively 
sudden onset of clinical diabetes.25 figure adapted with permission 
from taylor7 and reproduced with permission from taylor.26
very low density lipoprotein triglyceride. one tissue known to 
take up excess triglyceride supply avidly is the islet tissue of 
the pancreas.8–10 early data indicated that increasing levels 
of fat in the pancreas could decrease the acute insulin 
response to a raised glucose level.9 the diminishing real time 
insulin response would have the effect of producing greater 
postprandial hyperglycaemia, with prolongation of high insulin 
levels after meals, and steady onward progress of both the 
vicious cycles affecting liver and pancreas. 
Observations during reversal of type 2 
diabetes
the twin cycle hypothesis permitted testing of each of the 
predictions. the Counterpoint study followed a group of 
people with very ordinary type 2 diabetes during negative 
calorie balance. according to the hypothesis, the need to 
oxidise endogenous stored fuel should make the twin vicious 
cycles spin in the opposite direction. oral hypoglycaemic 
agents were stopped on day 1 of the low calorie diet. Within 7 
days liver fat levels had fallen by 30%, liver insulin sensitivity 
had normalised, and fasting plasma glucose had normalised. 
then, over the subsequent 8 weeks, the level of fat within 
the pancreas gradually decreased, and fi rst phase insulin 
response gradually returned.11
the later observation was striking and defi nitive. for decades, 
it had been assumed that fi rst phase insulin response could 
never be restored in type 2 diabetes. overall, the events 
predicted by the twin cycle hypothesis were shown to occur 
during an 8 week period of low calorie diet and weight loss of 
15 kg. both cycles could be made to spin in reverse. 
But what happened to muscle insulin 
resistance during the disappearance of the 
type 2 diabetic state?
euglycemic hyperinsulinemic clamp studies during the 
Counterpoint study allowed measurement of muscle insulin 
resistance, separate from that of the liver. no change in 
muscle insulin resistance occurred despite return to the 
non-diabetic state.11 Clearly, reversal of the muscle insulin 
resistance was not required to achieve normal glycaemia. 
Longer term observations 
it was necessary to conduct a further study to observe the 
long term physiology after reversal of type 2 diabetes. the 
Counterbalance study was designed to follow up individuals 
for six months after initial weight loss.12,13 it confi rmed the 
fi ndings of the Counterpoint study. in particular it showed 
that there was no change in muscle insulin resistance after 
reversal of type 2 diabetes, and only a trivial improvement 
over the six months of weight maintenance and continuation 
of non-diabetic glucose control.
The essential nature of type 2 diabetes
it can now be seen that muscle insulin resistance is a factor 
which expedites the accumulation of liver fat during the phase 
of developing the condition. muscle insulin resistance itself 
is not relevant to maintenance of the diabetic state (see box 
1). the cellular pathology of beta cell dysfunction in type 2 
diabetes is now amenable to a simple explanation. Presence 
of excess fat causes endoplasmic reticulum stress. this 
causes the beta cell to go into a ‘survival’ mode during which 
non-essential functions are shutdown. Producing insulin is not 
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essential for the survival of the beta cell and, unsurprisingly, 
the insulin gene production is switched off in this survival 
mode. however, at least for a period of a few years, these 
changes are reversible and removal of the excess fat allows 
redifferentiation of the beta cell. this sequence of events can 
now be described in relation to observations of physiology of 
reversal of type 2 diabetes.14
Insulin resistance in context
although insulin resistance is associated with physical 
inactivity, dyslipidaemia and increased risk of macrovascular 
disease, it is important to set in context its role in the 
development of type 2 diabetes. 
given that the degree of insulin resistance exhibited by 
people with type 2 diabetes overlaps entirely with that 
of the non-diabetic majority population,15 muscle insulin 
resistance can be seen not as a disease state per se, but 
as an individual characteristic which affects risk. it does not 
dictate pathogenesis.
the good news for people with type 2 diabetes is that they 
have a potentially reversible metabolic condition. large 
numbers of individuals who are strongly motivated have 
now returned their metabolic state to normal, and are off all 
medication.16 While these insights allow motivated people 
to make a profound difference to their own health, acquiring 
evidence upon which a change of guideline advice can be 
based is very different. it remains to be demonstrated how 
this can be applied to the management of all people with 
type 2 diabetes. a large study in primary care will test the 
practical applicability of the approach by randomisation to 
either weight loss plus a behavioural weight maintenance 
programme or to best care according to current guidelines.17 
direCt (diabetes remission Clinical trial) will report the one 
year outcomes this year. 
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